SEC 13F Intelligence

Foresite Capital Management IV, LLC / FULC

Foresite Capital Management IV, LLC’s Fulcrum Therapeutics Inc Position

Does Foresite Capital Management IV, LLC own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 1.13M shares worth $21M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$21M
Q2 2020
Shares
1.13M
% of Portfolio
+10.10%
Quarters Held
4
position exited

Position History FULC

Reported value by quarter
Q3 ’19: $11MQ3 ’19Q4 ’19: $25MQ4 ’19Q1 ’20: $12MQ1 ’20Q2 ’20: $21MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20201.13M$21M+10.10%
Q1 2020998.7K$12M+14.70%
Q4 20191.50M$25M+10.77%
Q3 20191.69M$11M+3.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of FULC.